Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTDSPL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | CD300A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CBLN3 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | ISLR | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
mRNA | DOC2B | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
mRNA | HIST1H4L | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |
mRNA | CXorf21 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
mRNA | MYBL1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
mRNA | TSKS | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
mRNA | FAM49A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |